
Paras Healthcare operates a network of multi-specialty tertiary care hospitals under the “Paras Health” brand, primarily focused on the healthcare markets of North India and East India. The company’s core business involves providing advanced healthcare services, including complex quaternary care and specialized therapeutic treatments. It manages eight operational hospitals across cities such as Gurugram, Patna, Panchkula, Ranchi, Udaipur, Srinagar, Darbhanga, and Kanpur, with a total bed capacity of 2,211 beds as of June 30, 2026. Paras Healthcare generates the majority of its revenue from in-patient department services, which include consultations, surgeries, and specialized treatments. The company’s revenue is heavily driven by six core clinical specialties: cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics and sports injury, and renal sciences. Additionally, the company generates a smaller portion of its income through in-house pharmacy sales and outpatient consultations.
GMP pointed to +2.16%; it listed at +4.04%, close to what the grey market expected.
| Day | Date | Retail | Small HNI | Big HNI | QIB | Total |
|---|---|---|---|---|---|---|
| Day 1 | 21st October 2026 | 0.73x | 0.14x | 0.05x | 0.00x | 0.15x |
| Day 2 | 22nd October 2026 | 1.37x | 0.33x | 0.23x | 0.07x | 0.36x |
| Day 3 | 23rd October 2026 | 2.10x | 0.84x | 0.62x | 3.25x | 2.34x |
| Category | Day 121-10-26 | Day 222-10-26 | Day 323-10-26 |
|---|---|---|---|
| Retail | 0.73x | 1.37x | 2.10x |
| Small HNI | 0.14x | 0.33x | 0.84x |
| Big HNI | 0.05x | 0.23x | 0.62x |
| QIB | 0.00x | 0.07x | 3.25x |
| Total | 0.15x | 0.36x | 2.34x |
Grey market premium is unofficial and indicative only.